1. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

   • Yojiro Hashiguchi
   • Kei Muro
   • Japanese Society for Cancer of the Colon and Rectum

   Special Article Open access 15 June 2019 Pages: 1 - 42

   

2. Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era

   • Minoru Suzuki

   Invited Review Article 05 June 2019 Pages: 43 - 50

   

3. Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts

   • Kosuke Murakami
   • Yasushi Kotani
   • Noriomi Matsumura

   Review Article 31 August 2019 Pages: 51 - 58

   

4. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma

   • Jingtai Zhi
   • Yu Wu
   • Ming Gao

   Original Article 14 August 2019 Pages: 59 - 66

   

5. Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC

   • Yoshiaki Amino
   • Satoru Kitazono
   • Makoto Nishio

   Original Article 10 September 2019 Pages: 67 - 73

   

6. Albumin–globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer

   • Yu Nakanishi
   • Takeshi Masuda
   • Noboru Hattori

   Original Article 17 September 2019 Pages: 74 - 81

   

7. Esophagectomy for the patients with squamous cell carcinoma of the esophagus after allogeneic hematopoietic stem cell transplantation

   • Fumihiko Kato
   • Hiroyuki Daiko
   • Kazuo Koyanagi

   Original Article 23 September 2019 Pages: 82 - 88

   

8. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer

   • Yuntao Shi
   • Zhonghong Wang
   • Zheng Liu

   Original Article 10 September 2019 Pages: 89 - 99

   

9. Increasing age-related survival gap among patients with colorectal cancer: a population-based retrospective study

   • Yang Feng
   • Shaobo Mo
   • Sanjun Cai

   Original Article 17 September 2019 Pages: 100 - 109

   

10. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer

    • Yukiharu Hiyoshi
    • Yuji Miyamoto
    • Hideo Baba

    Original Article 12 August 2019 Pages: 110 - 117

    

11. Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)

    • Norifumi Hattori
    • Goro Nakayama
    • Yasuhiro Kodera

    Original Article Open access 21 September 2019 Pages: 118 - 125

    

12. Feasibility of laparoscopic adrenalectomy for metastatic adrenal tumors in selected patients: a retrospective multicenter study of Japanese populations

    • Takayuki Goto
    • Takahiro Inoue
    • Osamu Ogawa

    Original Article 30 August 2019 Pages: 126 - 134

    

13. C-reactive protein and the neutrophil-to-lymphocyte ratio are prognostic biomarkers in metastatic renal cell carcinoma patients treated with nivolumab

    • Kotaro Suzuki
    • Tomoaki Terakawa
    • Masato Fujisawa

    Original Article 11 September 2019 Pages: 135 - 144

    

14. External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database

    • Stefan Zastrow
    • Laura-Maria Krabbe
    • Sabine Brookman-May

    Original Article 30 August 2019 Pages: 145 - 150

    

15. Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer

    • Ryo Fujiwara
    • Kentaro Inamura
    • Junji Yonese

    Original Article 14 September 2019 Pages: 151 - 157

    

16. Sarcopenia as a significant predictive factor of neutropenia and overall survival in urothelial carcinoma patients underwent gemcitabine and cisplatin or carboplatin

    • Tetsuya Yumioka
    • Masashi Honda
    • Atsushi Takenaka

    Original Article 13 September 2019 Pages: 158 - 164

    

17. Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial

    • Hiroyuki Nishiyama
    • Yoshiaki Yamamoto
    • Joaquim Bellmunt

    Original Article Open access 15 November 2019 Pages: 165 - 174

    

18. How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?

    • Yu Zhang
    • Na Zeng
    • Ye Tian

    Original Article 31 August 2019 Pages: 175 - 186

    

19. Impact of age on clinicopathological features and survival of epithelial ovarian neoplasms in reproductive age

    • Maya Hanatani
    • Nobuhisa Yoshikawa
    • Fumitaka Kikkawa

    Original Article 20 September 2019 Pages: 187 - 194

    

20. Prognostic significance of solid growth in endometrioid endometrial adenocarcinoma

    • Serra Akar
    • Zeliha Esin Çelik
    • Çetin Çelik

    Original Article 26 August 2019 Pages: 195 - 202

    

21. The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia

    • Shizuka Sato
    • Eiko Yamamoto
    • Fumitaka Kikkawa

    Original Article 13 September 2019 Pages: 203 - 209

22. Detection of bacteria in blood circulation in patients receiving cancer chemotherapy

    • Akiko Ota
    • Sachi Morita
    • Yuichi Ando

    Original Article 12 August 2019 Pages: 210 - 215